Intimate partner violence and condom and diaphragm nonadherence among women in an HIV prevention trial in southern Africa.

J Acquir Immune Defic Syndr

*Department of Biostatistics, Harvard School of Public Health, Boston, MA; †Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA; ‡RTI International, Women's Global Health Imperative, San Francisco, CA; §HIV Prevention Unit of the South African Medical Research Council, Durban, South Africa; ‖Sanofi Pasteur, Swiftwater, PA; ¶Ibis Reproductive Health, Cambridge, MA; #JSI Research and Training Institute, Washington, DC; **University of Zimbabwe, Harare, Zimbabwe; and ††Department of Medicine, Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, CA.

Published: December 2013

Background: We longitudinally examined the effect of intimate partner violence (IPV) on condom and diaphragm nonadherence among women in the Methods for Improving Reproductive Health in Africa study, a phase III HIV prevention trial in southern Africa.

Methods: Recent IPV (fear of violence, emotional abuse, physical violence, or forced sex, in past 3 months), condom nonadherence, and diaphragm nonadherence were assessed at baseline, 12 month, and exit visits (up to 24 months). The association between IPV and (1) condom nonadherence or (2) diaphragm nonadherence across visits was modeled using Generalized Estimating Equations adjusting for potential confounders.

Results: Of 4505 participants, 55% reported recent IPV during their trial participation. Women reported fearing violence (41%), emotional abuse (38%), being physically assaulted (16%), and forced sex (15%) by their regular male partner. IPV was associated with condom nonadherence in both study arms [adjusted odds ratio (AOR): 1.41, 95% confidence interval (CI): 1.24 to 1.61 (control arm) and AOR: 1.47, 95% CI: 1.28 to 1.69, (intervention arm)] and with diaphragm nonadherence (AOR 1.24, 95% CI: 1.06 to 1.45) adjusting for age, study sites, number of sex partners, and knowledge of male partner infidelity. Modeling effects of each form of IPV separately on nonadherence outcomes yielded similar results.

Conclusions: Prevalence of recent IPV was high and associated with condom and diaphragm nonadherence during the trial. Counseling in prevention trials should proactively address IPV, for its own sake, and in product and risk-reduction counseling. Strategies to encourage men's positive involvement in product use and prevent IPV perpetration should be considered.

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3182a6b0beDOI Listing

Publication Analysis

Top Keywords

diaphragm nonadherence
24
condom diaphragm
12
condom nonadherence
12
nonadherence
10
ipv
9
intimate partner
8
partner violence
8
nonadherence women
8
hiv prevention
8
prevention trial
8

Similar Publications

Expanded Endoscopic Endonasal Clipping of a Giant Cavernous Carotid Aneurysm.

World Neurosurg

December 2024

Saint Alphonsus Medical Group, Trinity Healthcare System, Boise, Idaho, USA.

Cavernous carotid aneurysms are typically small, asymptomatic, and often do not require treatment. We present the case of a 59-year-old woman, a 3-pack-a-day smoker, who presented with the primary complaint of left retro-orbital pain, left complete ophthalmoplegia, left-sided blindness, and right abducens palsy. Imaging revealed a giant right cavernous carotid aneurysm, which had expanded to the contralateral cavernous sinus wall and superiorly through the diaphragm sellae.

View Article and Find Full Text PDF
Article Synopsis
  • Product adherence significantly impacts the accurate evaluation of HIV-1 prevention methods like the dapivirine vaginal ring, with varying levels of adherence leading to biased efficacy estimates.* -
  • In the MTN-020/ASPIRE trial, per-protocol analyses indicated a 30.8% efficacy, while those with the highest adherence showed an efficacy of 53.6% when analyzing drug release from the ring.* -
  • Advanced statistical methods, such as principal stratification and marginal structural models, enhance our understanding of HIV-1 prevention effectiveness in clinical trials by adjusting for adherence levels.*
View Article and Find Full Text PDF

Couples-based interventions and postpartum contraceptive uptake: A systematic review.

Contraception

August 2022

Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States; Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN, United States.

Objective: Systematically review the existing evidence about couples-based interventions and postpartum contraceptive uptake and generate recommendations for future research.

Data Sources: PubMed, Web of Science, PsycINFO, Embase, and CINAHL through June 7, 2021.

Study Selection And Data Extraction: Studies with a couples-based intervention assessing postpartum contraceptive uptake.

View Article and Find Full Text PDF

Objectives: To determine the incidence of out-of-range segesterone acetate (NES) concentrations in participants of a pharmacokinetic/pharmacodynamic trial of a continuous use contraceptive vaginal ring (CVR) releasing NES and estradiol (E2). We hypothesized that out-of-range concentrations reflect nonadherent ring use and predict ovulation risk.

Study Design: We conducted a secondary analysis of data from a prospective, multi-centered, randomized, Phase IIa dose-finding trial for a CVR releasing NES and E2.

View Article and Find Full Text PDF

With persistently high global rates of unintended pregnancy and contraceptive nonuse, nonadherence and discontinuation, new contraceptive methods must address the needs of women and men who seek alternatives to their current options. Methods under development aim to reduce potential side effects, improve access and ease of use, ensure safety, increase secondary benefits associated with method use and expand options for both women and men. Developmental approaches employed to enhance current methods utilize new delivery systems and novel active pharmaceutical ingredients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!